Lin Zhao

机构：China National Institute of Standardization · ORCID：0000-0003-3999-4535

发表论文 32 篇 · 总被引 1086 次 · h-index 14

代表论文

• Antibody–Drug Conjugates (ADCs): current and future biopharmaceuticals (2025 · Journal of Hematology & Oncology · 被引 239)
• Effects of Farnesoid X Receptor Activation on Arachidonic Acid Metabolism, NF-kB Signaling, and Hepatic Inflammation (2018 · Molecular Pharmacology · 被引 91)
• Proteomics comparison of exosomes from serum and plasma between ultracentrifugation and polymer‐based precipitation kit methods (2019 · Electrophoresis · 被引 69)
• Lycorine and organ protection: Review of its potential effects and molecular mechanisms (2022 · Phytomedicine · 被引 52)
• Astaxanthin alleviates neuropathic pain by inhibiting the MAPKs and NF-κB pathways (2021 · European Journal of Pharmacology · 被引 43)
• Astaxanthin alleviates inflammatory pain by regulating the p38 mitogen-activated protein kinase and nuclear factor-erythroid factor 2-related factor/heme oxygenase-1 pathways in mice (2021 · Food & Function · 被引 26)